CD274 and cholangiocarcinoma: CD274-knockdown in cholangiocarcinoma cell lines resulted in increased tumorigenicity and aldehyde dehydrogenase (ALDH) activity, and CD274low cells are present in G0 phase6, suggesting that a CD274low fractions are enriched with dormant cancer stem cells.